Zusammenfassung
Hintergrund
Nach Strahlenbehandlung von Tumoren werden immer wieder Patienten beobachtet, die starke akute und späte Reaktionen in, normalen Geweben zeigen. Bei diesen Patienten liegt sehr häufig eine genetische Prädisposition vor. Es treten vor allem Defizienzen der DNA-Reparatur und Veränderungen der Regulation des Zellzyklus auf, die zu einer erhöhten Strahlenempfindlichkeit, mit verstärkter Zellabtötung führen.
Methodik
Der Mikronukleus-Test und der Comet Assay scheinen günstige Teste zu sein, um diese erhöhte Strahlenempfindlichkeit zu erfassen. Beide Teste zeichnen sich dadurch aus, daß sie relativ rasch und einfach mit geringen Zellzahlen durchgeführt werden können. Es können mit Hilfe dieses Testes Blutlymphozyten und Fibroblasten untersucht werden.
Ergebnisse
Beide Teste eignen sich insbesondere bei kombinierter Anwendung in hohem Maße, um eine Prädiktion der Strahlenempfindlichkeit normaler Gewebe durchzuführen.
Schlußfolgerung en
Epidemiologische Untersuchungen bei Patienten nach Strahlentherapie weisen verstärkt darauf hin, daß die erhöhte Strahlenempfindlichkeit auch zu einer vermehrten Bildung von Zweittumoren durch ionisierende Strahlen führt. Dieses wird durch entsprechende Tiermodelle unterstützt.
Abstract
Background
After radiotherapy there are always some patients, who develop strong acute and late reactions in normal tissues. In these patients frequently a genetic predisposition is observed. There are found DNA-repair deficiencies and changes in the regulation of the cell cycle which are responsible for the increased radiosensitivity with enhanced cell killing.
Methods
The micronucleus test and the comet assay appear to be appropriate tests in order to measure this increased radiosensitivity. Both tests are characterized by being relatively quick and simple and can be performed with small cell numbers. It is possible to study blood lymphocytes and fibroblasts with these tests.
Results
Both tests can predict the radiosensitivity of normal tissues especially if they are applied in combination.
Conclusions
Epidemiological studies with patients after radiotherapy show evidence that the increased radiosensitivity also causes an enhanced induction of secondary tumors by ionizing radiation. This is supported by corresponding animal models.
Literatur
Bauch, T.: Messung von DNA-Schäden und-Reparatur in Einzelzellen. Inaug.-Diss., Universität-Gesamthochschule Essen 1996.
Bouffler, S. D., C. J. Kemp, A. Balmain, R. Cox: Spontaneous and ionising radiation-induced chromosomal abnormalities in p53-deficient mice. Cancer Res. 55 (1995), 3883–3889.
Brock, W. A., S. L. Tucker, F. B. Geara, I. Turesson, J. Wike, J. Nyman, L. P. Peters: Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 32 (1995), 1371–1379.
Burnet, N. G., J. Nyman, I. Turesson, R. Wurm, J. R. Yarnold, J. H. Peacock The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules. Radiother. Oncol. 33 (1994), 228–238.
Cunliffe, P. N., J. R. Mann, A. H. Cameron, K. D. Roberts: Radiosensitivity in ataxia-telangiectasia. Brit. J. Radiol. 48 (1975), 374–376.
Donehower, L. A., M. Harvey, B. L. Slagle et al.: Mice deficient for p53 are developmentally normal but are susceptible to spontaneous tumours. Nature 356 (1992), 215–221.
Eng, C., F. P. Li, D. H. Abramson, R. M. Ellsworth, F. L. Wong M. B. Golman J. Seddon, N. Tarbell, J. D. Boice, Jr., Mortality from second tumors among long-term survivors of retinoblastoma. J. nat. Cancer Inst. 85 (1993), 1121–1128.
Fodde, R., W. Edelmann, K. Yang et al.: A targeted chain-terminating mutation in the mouse Apc gene results in multiple intestinal tumours. Proc. nat. Acad. Sci. (Wash.) 91 (1994), 8969–8973.
Gantenberg, H.-W., K. Wuttke, C. Streffer, W.-U. Müller: Micronuclei in human lymphocytes irradiated in vitro or in vivo. Radiat. Res. 128 (1991). 276–281.
German, J.: Patterns of neoplasia associated with the chromosome breakage syndromes. In: German, J.: Chromosome mutation and neoplasia. Alan R. Liss, New York 1983, p. 97–134.
Gotoff, S. P., E. Amirmokri, E. J. Liebner: Ataxia telangiectasia: neoplasia, untoward response to X-irradiation, and tuberous sclerosis. Amer. J. Dis. Child., 114 (1967), 617–625.
Harvey, M., M. J. McArthur, C. A. Montgomery et al.: Spontaenous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Genet. 5 (1993), 225–229.
Jacks, T., T. S. Shih, E. M. Schmitt et al.: Tumour predisposition in mice heterozygous for a targeted mutation in Nfl. Nature Genet. 7 (1994), 353–358.
Kemp, C. J., T. Wheldon, A. Balmain: p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nature Genet. 8 (1994), 66–69.
Little, J. B.: Changing views of cellular radiosensitivity. Radiat. Res. 140 (1994), 299–311.
Loeffler J. S., J. R. Harris, W. K. Dahlberg, J. B. Little: In vitro radiosensitivity of human diploid fibroblasts derived from women with unusually sensitive clinical responses to definitive radiation therapy for breast cancer. Radiat. Res. 121 (1990), 227–231.
Morgan, J. L., T. M. Holcomb, R. W. Morrissey: Radiation reaction in ataxia telangiectasia. Amer. J. Dis. Child. 116 (1968), 557–558.
Moser, A. R., H. C. Pitot, W. F. Dove: A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247 (1990), 322–324.
Müller, W.-U., T. Bauch, C. Streffer, F. Niedereichholz, W. Böcker: Comet assay studies of radiation-induced DNA damage and repair in various tumour cell lines. Int. J. Radiat. Biol. 65 (1994), 315–319.
Murnane J. P., L. N. Kapp: A critical look at the association of human genetics syndromes with sensitivity to ionising radiation Semin. Cancer Biol. 4 (1993), 93–104.
Östling, O., K. J. Johanson: Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem. biophys. Res. Commun. 123 (1984), 291–298.
Roifman, C. M., E. W. Gelfand: Heterogeneity of the immunological deficiency in ataxia-telangiectasia. In: Gatti, R. A., M. Swift: Ataxia-telangiectasia: genetics, neuropathology and immunology of a degenerative disease of childhood. Alan R. Liss, New York 1985, p. 273–285.
Scott, D., A. Spreadborough, E. Levine, S. A. Roberts: Genetic predisposition in breast cancer. Lancet 344 (1994), 1444.
Streffer, C.: Is the micronucleus assay preditive for cellular radiosensitivity? Brit. J. Radiol., Suppl. 24 (1992), 70–73.
Streffer, C., D. van Beuningen, E. Gross, J. Schabronath, F.-W. Eigler, A. Rebmann: Predictive assays for the therapy of rectum carcinoma. Radiother. Oncol. 5 (1986), 303–310.
Swift, M., D. Morrell, R. B. Massey, C. L. Chase: Incidence of cancer in 161 families affected by ataxia-telangiectasia. New Engl. J Med. 325 (1991), 1831–1836.
Tucker, M. A., A. T. Meadows, J. D. Boice et al.: Cancer risk following treatment of childhood cancer. In: Boice, J. D., J. F. Fraumeni: Radiation carcinogenesis, epidemiology and biological significance. Raven Press, New York, 1984, p. 211–224.
UNSCEAR: Sources and effects of ionizing radiation. United Nations Scientific Committee on the Effects of Atomic Radiation. United Nations. New York 1993.
Weissenborn, U., C. Streffer: Micronuclei with kinetochores in human melanoma cells and rectal carcinomas. Int. J. Radiat. Biol. 59 (1991). 373–383.
Wuttke, K.: Mikronuklei in Lymphozyten als biologischer Indikator für Strahlen-Expositionen. Inaug.-Diss., Universität—Gesamthochschule Essen 1993.
Wuttke, K., C. Streffer W.-U. Müller: Radiation-induced micronuclei in subpopulations of human lymphocytes. Mutat. Res. 286 (1993), 181–188.
Author information
Authors and Affiliations
Additional information
Vorgetragen beim 2. Kongreß der Deutschen Gesellschaft für Radioonkologie. 16–19.11.1996, Baden-Baden.
Rights and permissions
About this article
Cite this article
Streffer, C. Genetische Prädisposition und Strahlenempfindlichkeit bei normalen Geweben. Strahlenther. Onkol. 173, 462–468 (1997). https://doi.org/10.1007/BF03038185
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03038185